Anand Kapila K reported grant involving 12,196 shares of Elanco Animal Health Inc at $0.00 for $0 on May 21, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Director
DIR
Filed May 26, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$0Shares × reported price
Shares traded
12,196Common Stock
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
111,847Direct
Trade date
May 21, 2026Grant
Filed
May 26, 2026, 4:43 PM ET5-day reporting delay
Accession
0001679166-26-000006Code A · Transaction 386201
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
May 21, 2026Grant4,678$0.00$0Trade 386200
2 transaction rows in this filing. Joint filers share the same rows.

ELAN price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
ELAN · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −0.9%1w ago −5.2%1d ago −8.6%
Returns since7d +3.5%30d +6.8%90d +7%180d1y

Footnotes in full

F1: Grant of deferred stock units as a pro-rated annual equity award to each of the non-employee members of the Issuer's Board of Directors. F2: Grant of restricted stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors.